identify high-value, de-risked targets at speed and scale for rare genetic diseases
H. RES. 1330 H.R. 6216/S. 3389, the Sickle Cell Disease Comprehensive Care Act H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 S. 1644/H.R. 3761, the Promising Pathway Act S. 373/H.R. 4472, the BENEFIT Act of 2021 H.R.2623, Camerons Law
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE KPM GROUP DC LLC
1455 PENNSYLVANIA AVE NW, Unit 1150, Washington, DC, 20004, US
ALEXANDER ROOT KATHERINE LANDES